Quick Answer
Disc Medicine, Inc. reported Long-Term Debt of $29.16 million for fiscal year 2025.
Disc Medicine, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $29.16M | +3.0% |
| 2024 | $28.32M | — |
| 2023 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $28.95M | — | +0.7% |
| June 30, 2025 | $28.74M | — | +0.7% |
| March 31, 2025 | $28.53M | — | +0.7% |
| December 31, 2024 | $28.32M | — | — |
- Disc Medicine, Inc. showed an increase of +3.0% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Disc Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: